Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Vaccines

Free Subscription 18.06.2018 1 Ann N Y Acad Sci 1 Clin Infect Dis 1 J Infect Dis 1 J Virol 1 Lancet Glob Health 2 Lancet HIV 3 N Engl J Med 1 Pediatr Infect Dis J 5 PLoS One 29 Vaccine 2 Virology

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Ann N Y Acad Sci

1. SIDDIQUI AJ, Molehin AJ, Zhang W, Ganapathy PK, et al
   Sm-p80-based vaccine trial in baboons: efficacy when mimicking natural conditions of chronic disease, praziquantel therapy, immunization, and Schistosoma mansoni re-encounter.
   Ann N Y Acad Sci. 2018 Jun 11. doi: 10.1111/nyas.13866.
   PubMed     Text format     Abstract available
   
   

   
   Clin Infect Dis

2. TRIEU MC, Jul-Larsen A, Saevik M, Madsen A, et al
   Antibody responses to influenza A/H1N1pdm09 virus after pandemic and seasonal influenza vaccination in healthcare workers: a five-year follow-up study.
   Clin Infect Dis. 2018 Jun 9. pii: 5035295. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   

   
   J Infect Dis

3. LIU Y, Ye L, Lin F, Gomaa Y, et al
   Intradermal Vaccination With Adjuvanted Ebola Virus Soluble Glycoprotein Subunit Vaccine by Microneedle Patches Protects Mice Against Lethal Ebola Virus Challenge.
   J Infect Dis. 2018 Jun 8. pii: 5034941. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   

   
   J Virol

4. KHAN AA, Srivastava R, Vahed H, Roy S, et al
   Human Asymptomatic Epitope Peptide/CXCL10-Based Prime/Pull Vaccine Induces Herpes Simplex Virus-Specific Gamma Interferon-Positive CD107(+) CD8(+) T Cells That Infiltrate the Cornea and Trigeminal Ganglia of Humanized HLA Transgenic Rabbits and Protec
   J Virol. 2018 Jun 13. pii: JVI.00535-18. doi: 10.1128/JVI.00535.
   PubMed     Text format     Abstract available
   
   

   
   Lancet Glob Health

5. SHEARER FM, Longbottom J, Browne AJ, Pigott DM, et al
   Existing and potential infection risk zones of yellow fever worldwide: a modelling analysis.
   Lancet Glob Health. 2018;6:e270-e278.
   PubMed     Text format     Abstract available
   
   

   
   Lancet HIV

6. BAROUCH DH
   A step forward for HIV vaccines.
   Lancet HIV. 2018 Jun 8. pii: S2352-3018(18)30095.
   PubMed     Text format    
   
   
7. BEKKER LG, Moodie Z, Grunenberg N, Laher F, et al
   Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial.
   Lancet HIV. 2018 Jun 8. pii: S2352-3018(18)30071.
   PubMed     Text format     Abstract available
   
   

   
   N Engl J Med

8. ROSENBAUM L
   Trolleyology and the Dengue Vaccine Dilemma.
   N Engl J Med. 2018 Jun 13. doi: 10.1056/NEJMp1804094.
   PubMed     Text format    
   
   
9. SHINDE V, Fries L, Wu Y, Agrawal S, et al
   Improved Titers against Influenza Drift Variants with a Nanoparticle Vaccine.
   N Engl J Med. 2018;378:2346-2348.
   PubMed     Text format    
   
   
10. SRIDHAR S, Luedtke A, Langevin E, Zhu M, et al
    Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy.
    N Engl J Med. 2018 Jun 13. doi: 10.1056/NEJMoa1800820.
    PubMed     Text format     Abstract available
    
    

    
    Pediatr Infect Dis J

11. MAKWANA A, Sheppard C, Borrow R, Fry N, et al
    Characteristics of Children With Invasive Pneumococcal Disease After the Introduction of the 13-valent Pneumococcal Conjugate Vaccine in England and Wales, 2010-2016.
    Pediatr Infect Dis J. 2018;37:697-703.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

12. CHAO YH, Chen DY, Lan JL, Tang KT, et al
    Tolerogenic beta2-glycoprotein I DNA vaccine and FK506 as an adjuvant attenuates experimental obstetric antiphospholipid syndrome.
    PLoS One. 2018;13:e0198821.
    PubMed     Text format     Abstract available
    
    
13. POTTINGER HL, Jacobs ET, Haenchen SD, Ernst KC, et al
    Parental attitudes and perceptions associated with childhood vaccine exemptions in high-exemption schools.
    PLoS One. 2018;13:e0198655.
    PubMed     Text format     Abstract available
    
    
14. MOHAMMED H, Clarke M, Koehler A, Watson M, et al
    Factors associated with uptake of influenza and pertussis vaccines among pregnant women in South Australia.
    PLoS One. 2018;13:e0197867.
    PubMed     Text format     Abstract available
    
    
15. TAYLOR WD JR, Langham GL, Weed JL, Rowe T, et al
    The effects of repeated automated plasmapheresis in goats (Capra hircus) in response to vaccination with purified influenza hemagglutinin proteins.
    PLoS One. 2018;13:e0195903.
    PubMed     Text format     Abstract available
    
    
16. LASSETER G, Al-Janabi H, Trotter CL, Carroll FE, et al
    The views of the general public on prioritising vaccination programmes against childhood diseases: A qualitative study.
    PLoS One. 2018;13:e0197374.
    PubMed     Text format     Abstract available
    
    

    
    Vaccine

17. BENNETT A, Pollock L, Jere KC, Pitzer VE, et al
    Direct and possible indirect effects of vaccination on rotavirus hospitalisations among children in Malawi four years after programmatic introduction.
    Vaccine. 2018 Jun 7. pii: S0264-410X(18)30513.
    PubMed     Text format     Abstract available
    
    
18. BAAY M, Bollaerts K, Verstraeten T
    A systematic review and meta-analysis on the safety of newly adjuvanted vaccines among older adults.
    Vaccine. 2018 Jun 6. pii: S0264-410X(18)30815.
    PubMed     Text format     Abstract available
    
    
19. PHILLIPS DE, Dieleman JL, Shearer JC, Lim SS, et al
    Childhood vaccines in Uganda and Zambia: Determinants and barriers to vaccine coverage.
    Vaccine. 2018 Jun 6. pii: S0264-410X(18)30795.
    PubMed     Text format     Abstract available
    
    
20. MODI RN, King C, Bar-Zeev N, Colbourn T, et al
    Caregiver recall in childhood vaccination surveys: Systematic review of recall quality and use in low- and middle-income settings.
    Vaccine. 2018 Jun 6. pii: S0264-410X(18)30755.
    PubMed     Text format     Abstract available
    
    
21. HU K, Fu M, Guan X, Zhang D, et al
    Penton base induces better protective immune responses than fiber and hexon as a subunit vaccine candidate against adenoviruses.
    Vaccine. 2018 Jun 7. pii: S0264-410X(18)30797.
    PubMed     Text format     Abstract available
    
    
22. MCGREGOR S, Saulo D, Brotherton J, Liu B, et al
    Decline in prevalence of human papillomavirus infection following vaccination among Australian Indigenous women, a population at higher risk of cervical cancer: The VIP-I study.
    Vaccine. 2018 Jun 4. pii: S0264-410X(18)30771.
    PubMed     Text format     Abstract available
    
    
23. FOSTER M, Pandey A, Kreimeyer K, Botsis T, et al
    Generation of an annotated reference standard for vaccine adverse event reports.
    Vaccine. 2018 Jun 4. pii: S0264-410X(18)30745.
    PubMed     Text format     Abstract available
    
    
24. RUSSO R, Bozzola E, Villani A
    Immunization of preterms with hexavalent combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine: The position of the Italian Pediatric Society.
    Vaccine. 2018 Jun 4. pii: S0264-410X(18)30794.
    PubMed     Text format    
    
    
25. PRINCIPI N, Esposito S
    Vaccine-preventable diseases, vaccines and Guillain-Barre' syndrome.
    Vaccine. 2018 Jun 4. pii: S0264-410X(18)30798.
    PubMed     Text format     Abstract available
    
    
26. FAN X, Su Q, Qiu F, Yi Y, et al
    Intranasal inoculate of influenza virus vaccine against lethal virus challenge.
    Vaccine. 2018 Jun 4. pii: S0264-410X(18)30739.
    PubMed     Text format     Abstract available
    
    
27. TASHANI M, Alfelali M, Barasheed O, Alqahtani AS, et al
    Effect of Tdap upon antibody response to meningococcal polysaccharide when administered before, with or after the quadrivalent meningococcal TT-conjugate vaccine (coadministered with the 13-valent pneumococcal CRM197-conjugate vaccine) in adult Hajj p
    Vaccine. 2018 Jun 4. pii: S0264-410X(18)30516.
    PubMed     Text format     Abstract available
    
    
28. KIELY M, Boulianne N, Talbot D, Ouakki M, et al
    Impact of the addition of new vaccines in the early childhood schedule on vaccine coverage by 24months of age from 2006 to 2016 in Quebec, Canada.
    Vaccine. 2018 Jun 7. pii: S0264-410X(18)30463.
    PubMed     Text format     Abstract available
    
    
29. GILCA V, Salmeron-Castro J, Sauvageau C, Ogilvie G, et al
    Early use of the HPV 2-dose vaccination schedule: Leveraging evidence to support policy for accelerated impact.
    Vaccine. 2018 Jun 7. pii: S0264-410X(18)30168.
    PubMed     Text format     Abstract available
    
    
30. PEZZOTTI P, Miglietta A, Neri A, Fazio C, et al
    Meningococcal C conjugate vaccine effectiveness before and during an outbreak of invasive meningococcal disease due to Neisseria meningitidis serogroup C/cc11, Tuscany, Italy.
    Vaccine. 2018 Jun 9. pii: S0264-410X(18)30813.
    PubMed     Text format     Abstract available
    
    
31. ENGELHARDT OG, Edge C, Dunleavy U, Guilfoyle K, et al
    Comparison of single radial immunodiffusion, SDS-PAGE and HPLC potency assays for inactivated influenza vaccines shows differences in ability to predict immunogenicity of haemagglutinin antigen.
    Vaccine. 2018 Jun 9. pii: S0264-410X(18)30742.
    PubMed     Text format     Abstract available
    
    
32. HENKE J, Carlson J, Zani L, Leidenberger S, et al
    Protection against transplacental transmission of moderately virulent classical swine fever virus using live marker vaccine "CP7_E2alf".
    Vaccine. 2018 Jun 9. pii: S0264-410X(18)30830.
    PubMed     Text format     Abstract available
    
    
33. DOBROVOLSKIENE N, Pasukoniene V, Darinskas A, Krasko JA, et al
    Tumor lysate-loaded Bacterial Ghosts as a tool for optimized production of therapeutic dendritic cell-based cancer vaccines.
    Vaccine. 2018 Jun 9. pii: S0264-410X(18)30832.
    PubMed     Text format     Abstract available
    
    
34. RUSSO P, Ligsay AD, Olveda R, Choi SK, et al
    A randomized, observer-blinded, equivalence trial comparing two variations of Euvichol(R), a bivalent killed whole-cell oral cholera vaccine, in healthy adults and children in the Philippines.
    Vaccine. 2018 Jun 9. pii: S0264-410X(18)30769.
    PubMed     Text format     Abstract available
    
    
35. JOYCE C, Scallan CD, Mateo R, Belshe RB, et al
    Orally administered adenoviral-based vaccine induces respiratory mucosal memory and protection against RSV infection in cotton rats.
    Vaccine. 2018 Jun 9. pii: S0264-410X(18)30789.
    PubMed     Text format     Abstract available
    
    
36. HILL S, Entwisle C, Pang Y, Joachim M, et al
    Immunogenicity and mechanisms of action of PnuBioVax, a multi-antigen serotype-independent prophylactic vaccine against infection with Streptococcus pneumoniae.
    Vaccine. 2018 Jun 9. pii: S0264-410X(18)30801.
    PubMed     Text format     Abstract available
    
    
37. ZHANG Y, Huang S, Zeng Y, Xue C, et al
    Rapid development and evaluation of a live-attenuated QX-like infectious bronchitis virus vaccine.
    Vaccine. 2018 Jun 8. pii: S0264-410X(18)30820.
    PubMed     Text format     Abstract available
    
    
38. WALKER WL, Hills SL, Miller ER, Fischer M, et al
    Adverse events following vaccination with an inactivated, Vero cell culture-derived Japanese encephalitis vaccine in the United States, 2012-2016.
    Vaccine. 2018 Jun 8. pii: S0264-410X(18)30521.
    PubMed     Text format     Abstract available
    
    
39. DYDA A, McIntyre P, Karki S, MacIntyre CR, et al
    Pertussis vaccination in a cohort of older Australian adults following a cocooning vaccination program.
    Vaccine. 2018 Jun 7. pii: S0264-410X(18)30786.
    PubMed     Text format     Abstract available
    
    
40. CHESSON HW, Meites E, Ekwueme DU, Saraiya M, et al
    Cost-effectiveness of nonavalent HPV vaccination among males aged 22 through 26years in the United States.
    Vaccine. 2018 Jun 7. pii: S0264-410X(18)30578.
    PubMed     Text format     Abstract available
    
    
41. VALKENBURG SA, Li OTW, Li A, Bull M, et al
    Protection by universal influenza vaccine is mediated by memory CD4 T cells.
    Vaccine. 2018 Jun 7. pii: S0264-410X(18)30818.
    PubMed     Text format     Abstract available
    
    
42. LI Q, Xu Z, Wu T, Peng O, et al
    A flagellin-adjuvanted PED subunit vaccine improved protective efficiency against PEDV variant challenge in pigs.
    Vaccine. 2018 Jun 8. pii: S0264-410X(18)30822.
    PubMed     Text format     Abstract available
    
    
43. LABASTIDA-CONDE RG, Ramirez-Pliego O, Peleteiro-Olmedo M, Lopez-Guerrero DV, et al
    Flagellin is a Th1 polarizing factor for human CD4(+) T cells and induces protection in a murine neonatal vaccination model of rotavirus infection.
    Vaccine. 2018 Jun 8. pii: S0264-410X(18)30816.
    PubMed     Text format     Abstract available
    
    
44. TAN N, Sharma M, Winer R, Galloway D, et al
    Model-estimated effectiveness of single dose 9-valent HPV vaccination for HIV-positive and HIV-negative females in South Africa.
    Vaccine. 2018 Jun 8. pii: S0264-410X(18)30197.
    PubMed     Text format     Abstract available
    
    
45. LIN YL, Cheng PY, Chin CL, Huang LM, et al
    Fibroblast-stimulating lipopeptide-1 as a potential mucosal adjuvant enhances mucosal and systemic immune responses to enterovirus 71 vaccine.
    Vaccine. 2018 Jun 8. pii: S0264-410X(18)30756.
    PubMed     Text format     Abstract available
    
    

    
    Virology

46. BODMER BS, Fiedler AH, Hanauer JRH, Prufer S, et al
    Live-attenuated bivalent measles virus-derived vaccines targeting Middle East respiratory syndrome coronavirus induce robust and multifunctional T cell responses against both viruses in an appropriate mouse model.
    Virology. 2018;521:99-107.
    PubMed     Text format     Abstract available
    
    
47. BOWDER D, Thompson J, Durst K, Hollingsead H, et al
    Characterization of twin-cysteine motif in the V2-loop region of gp120 in primate lentiviruses.
    Virology. 2018;519:180-189.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: